Filing Flows › Aspen Aerogels (ASPN) › Guidance history
Aspen Aerogels (ASPN) guidance history: what it guided and what it reported
Aspen Aerogels gave guidance in 3 earnings releases on file since May 7, 2026. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +15.4% against the guided midpoint.
Revenue
Met or beat 2 of 2 periods (2 above, 0 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | $60.0M–$75.0M (Nov 5, 2026) | — | to be reported | — |
| Q3 2026 | $65.0M–$80.0M (Aug 6, 2026) | $85.2M | above the range | +17.5% |
| Q2 2026 | $40.0M–$48.0M (May 7, 2026) | $49.8M | above the range | +13.3% |
Adjusted revenue
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q3 2026 | $65.0M–$80.0M (Aug 6, 2026) | — | — | — |
Net income
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | $8.0M–$11.0M (Nov 5, 2026) | — | to be reported | — |
| Q3 2026 | $6.0M–$9.0M (Aug 6, 2026) | — | — | — |
| FY2026 | −$20.0M (May 7, 2026) → raised −$9.0M (Aug 6, 2026) | — | to be reported | — |
| Q2 2026 | $14.0M–$20.0M (May 7, 2026) | — | — | — |
EPS
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | $0.10–$0.13 (Nov 5, 2026) | — | to be reported | — |
| Q3 2026 | $0.07–$0.11 (Aug 6, 2026) | — | — | — |
| Q2 2026 | $0.17–$0.24 (May 7, 2026) | — | — | — |
Capital expenditures
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $10.0M (May 7, 2026) | — | to be reported | — |
Depreciation & amortization
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | $5.0M (Nov 5, 2026) | — | to be reported | — |
| Q3 2026 | $5.0M (Aug 6, 2026) | — | — | — |
| FY2026 | $5.0M (May 7, 2026) → reaffirmed $5.0M (Aug 6, 2026) | — | to be reported | — |
| Q2 2026 | $5.0M (May 7, 2026) | — | — | — |
The latest quarter
Aspen Aerogels, Q3 2026: revenue $85.2M (+17% year over year), operating margin -8.4%, net loss $10.4M, operating cash flow −$3.8M. The chart follows the revenue to costs, profit and cash.
Questions
Does Aspen Aerogels beat its guidance?
Aspen Aerogels gave guidance in 3 earnings releases on file since May 7, 2026. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +15.4% against the guided midpoint.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.